MLN4924 is an investigational small molecule inhibitor of the NEDD8-activating enzyme (NAE) in Phase I clinical trials. NAE inhibition prevents the ubiquitination and proteasomal degradation of substrates for cullin-RING ubiquitin E3 ligases that support cancer pathophysiology, but the genetic determinants conferring sensitivity to NAE inhibition are unknown. To address this gap in knowledge, we conducted a genome-wide siRNA screen to identify genes and pathways that affect the lethality of MLN4924 in melanoma cells. Of the 154 genes identified, approximately one-half interfered with components of the cell cycle, apoptotic machinery, ubiquitin system and DNA damage response pathways. In particular, genes involved in DNA replication, p53, BRCA1/BRCA2, transcription-coupled repair and base excision repair appeared to be important for MLN4924 lethality. In contrast, genes within the G2/M checkpoint affected sensitivity to MLN4924 in colon cancer cells. Cell cycle analysis in melanoma cells by flow cytometry following RNAi-mediated silencing demonstrated that MLN4924 prevented the transition of cells from S to G2 phase after induction of rereplication stress. Our analysis suggested an important role for the p21-dependent intra-S-phase checkpoint and extensive rereplication, whereas the ATR-dependent intra-S-phase checkpoint appeared to play a less dominant role. Unexpectedly, induction of the p21-dependent intra-S-phase checkpoint appeared to be independent of both Cdt1 stabilization and ATR signaling. Collectively, these data enhance our understanding of the mechanisms by which inhibition of NEDD8-dependent ubiquitination causes cell death, informing clinical development of MLN4924.
(1) MLN4924 has demonstrated antitumor activity in multiple xenograft models of human cancer at well tolerated doses (1) (2) (3) . MLN4924 is currently being explored in Phase I clinical trials, where some clinical activity has been observed in solid tumor and hematological malignancies (4) . Therefore, a more complete understanding of the impact of NAE inhibition on cancer cell biology is warranted.
NAE catalyzes the activation and transfer of NEDD8 onto Ubc12 and Nce2 in an ATPdependent manner (5) . Activated NEDD8 is then transferred onto one of eight cullins in a DCN1-dependent manner (6, 7) . Neddylation of the cullins results in activation of the class of E3 ubiquitin ligases known as the cullin-RING ligases (CRLs). These enzymes conjugate proteins with Lys48-linked polyubiquitin chains (8, 9) , thereby promoting the degradation of a relatively small subset of proteasomal substrates (1) . CRLs have been shown to monoubiquitinate some proteins, especially histones (9) . Recently, the function of Cul1-Rbx1-Skp1 (CRL1) has been expanded to include Lys63-linked polyubiquitin chain formation (10) .
Initial studies to define the mechanism of action of MLN4924 have demonstrated that blocking of CRL1-Skp2 and Cul4-Rbx1-Ddb1 (CRL4)-Cdt2 function results in Cdt1 stabilization, which leads to DNA rereplication and accumulation of cells in S-phase, thereby promoting cell death in most cancer cell lines studied (1, 11, 12) , although stabilization of IκB via inhibition of CRL1-βTRCP plays a role in some settings (2).
In order to prevent genomic instability, initiation of DNA replication is tightly controlled by a well orchestrated process that involves the origin recognition complex (ORC), Cdc6, Cdt1, MLN4924 Genome-wide RNAi Screen 10/18/2012 DNA replication initiated by the protein kinases Cdk2 and Dbf4-Cdc7, Cdt1 is degraded, while Cdc6 is exported from the nucleus, thereby preventing refiring of the origin. Degradation of Cdt1 is controlled in a Cdk2-dependent manner by CRL1-Skp2 and in a PCNA-dependent manner by CRL4-Cdt2 (18) (19) (20) (21) . Cdt2 is also known as DTL.
DNA rereplication results from the multiple refiring of the origins of replication during DNA synthesis, generally resulting in partial polyploidy (16) . Overexpression of CDT1 or CDC6, or depletion of GMNN, encoding an inhibitor of Cdt1, can induce DNA rereplication in some tumor cell lines, although checkpoint control is activated in normal cells and in other tumor cell lines (22, 23) .
Several studies have demonstrated that cullin-dependent ubiquitination along with the COP9 signalosome, which is responsible for deneddylation of the cullins, have additional roles in DNA damage response pathways. These include global genome and transcription-coupled nucleotide excision repair, histone modification, and regulation of checkpoints via degradation of p21, p27, p53, Cdc25A, Wee1, claspin, and FANCM (9, (24) (25) (26) (27) . Therefore, it is likely that inhibition of NAE by MLN4924 impacts multiple DNA damage response pathways beyond those involving Cdt1 stabilization. Therefore, to ascertain the relative importance of these potentially diverse mechanisms, we have performed a genome-wide siRNA screen to evaluate the genetics of sensitivity to MLN4924 in the A375 human melanoma-derived cell line. RNA interference (RNAi) screens provide an important avenue for understanding the sensitivity of tumor cells to drugs and drug candidates (28) (29) (30) .
This screen identified 154 genes whose knock-down had significant effects on MLN4924-induced cell death. Collectively, the data suggest that NAE inhibition by MLN4924 The cDNA to be used for the qPCR reactions was generated using ABI TaqMan Gene Expression Cells-to-CT kit (Applied Biosystems #AM1729) according to manufacturer's protocols and was performed on Biomek® FX Liquid Handling System. TaqMan Gene Expression Assays kits were purchased from Applied Biosystems and data were generated with an ABI7900HT system. Figure S1 . Antibody details are presented in Supplementary Table S1A . Table S1D and S1E, Supplementary Fig. S4 ).
Using permutation analysis and confirmation of gene expression (Supplementary Table   S1F & S1G), 109 hits were identified with an FDRp<0.05 based on three out of the four oligos interacting with MLN4924 (O3 criteria, Table 1 ). An additional 45 hits were identified with a 0.05<FDRp<0.10 based on three out of four oligos (O3* criteria). These hits were classified according to their gene annotation (Fig. 1) .
Importantly, the screen captured key aspects of biology previously shown to be important for MLN4924 mechanism of action, including genes involved in the ubiquitin pathway, DNA damage repair, cell cycle, TNF family receptors and apoptosis. However, genes within the p53 pathway, BRCA1/BRCA2 complex, transcription-coupled and base excision repair pathways were identified that had not previously been implicated in the mechanism of cell death induced by MLN4924. These hits represent genes whose function may be directly dysregulated by MLN4924. In interpreting RNAi screens, it is important to remember key limitations of RNAi, including transient protein knock-down, incomplete elimination of the protein, genetic redundancy and off-target effects.
Consistent with NAE being the primary target of MLN4924, the two hits with the greatest degree of synthetic lethality following deconvolution (Table 1) were UBA3 and NAE1, encoding the heterodimeric subunits of NAE. Depletion of either UBA3 or NAE1 by RNAi in cells therefore appears to reduce the effective concentration of MLN4924 required to achieve a critical level of inhibition of the NEDD8 pathway that results in cell death.
The hits with the greatest degree of suppression of MLN4924-induced lethality included CDT1, CASP8, and TEX10, a protein associated with the SLX4 Holliday junction resolvase (32) .
Depletion of CDT1 would be expected to reduce prereplication licensing, thereby preventing cell death, consistent with its scoring as a suppressor. Hits were also evaluated using two or four out of four oligos (O2 and O4 criteria, Supplementary Table S2A-B), although these criteria captured fewer hits. Table S2C ). Fewer hits were identified by either O2 or O3 criteria (Supplementary Table S1I ). With the exception of the TCR/BER gene set, the depletion of the DNA damage repair and cell cycle genes that impacted A375 sensitivity of MLN4924 did not similarly impact HCT-116 sensitivity. Since HCT-116 rereplicates its DNA following treatment with MLN4924 even more substantially than does A375 ( Supplementary   Fig. S2 ), we hypothesized that genetic differences in DNA damage repair mechanisms between A375 and HCT-116 may substantially impact the response to MLN4924. Therefore, deconvoluted siRNA oligos against 317 genes with known DNA damage response roles were evaluated in HCT-116 cells at 91 nM MLN4924 (Supplementary Table S1H & S1I, Run 3), of which 9 scored as hits (Supplementary Table S2C , annotated with #). Notably, 6 of these have known roles within the G2/M checkpoint, with knock-down of FBXO5 (encoding Emi1), CDK1, and PLK1 giving the most significant effects.
Cell Cycle Interactions of Hits with MLN4924
MLN4924 induces DNA rereplication by stabilizing the replication licensing factor Cdt1 (12) . To quantify the effect of MLN4924 on the cell cycle and in order to better characterize how MLN4924 might affect previously studied rereplication checkpoints, A375 cells transfected with control siRNA (GL2) were treated with vehicle or 500 nM MLN4924 for 22 h, pulse-labeled with BrdU, stained with propidium iodide, and then subjected to flow cytometry ( Fig. 2A) .
MLN4924 resulted in changes to most phases of the cell cycle (Fig. 2B) , including increases in the number of cells with S-phase DNA content but not incorporating BrdU (labeled as 2N-4N) and cells with greater than 4N DNA actively incorporating BrdU. Of note, sub-G1 cells were not captured in this analysis due to their loss in plate-washing.
We evaluated the effect of depleting 11 genes directly associated with the prereplication complex or origin firing, as well as UBA3 (Fig. 2C) We also evaluated the effect of knock-down of a further 86 genes that function more broadly in cell cycle and DNA damage responses for changes to the cell cycle effects of MLN4924. In total, depletion of 69 genes significantly impacted the cell cycle distribution following MLN4924 treatment (Fig. 3, Supplementary Fig. S5, Supplementary Table S1J ). 
Extent of Rereplication Does Not Significantly Correlate with Cell Death
Surprisingly, these cell cycle changes (Fig. 2C, 3 & Supplementary Fig. S5 ) did not significantly correlate with the viability effects of genes with significant MLN4924 interactions.
Genes whose knock-down resulted in the significant accumulation of cells in G1 for vehicletreated cells were marginally negatively associated with a synthetic lethal phenotype (5 of 22, p = 0.18). Genes whose knock-down led to increased >4N DNA content following MLN4924 treatment were marginally negatively associated with a suppressor phenotype (2 of 8, p = 0.14).
Thus, S-phase content prior to treatment appears to be important for MLN4924 sensitivity and increased >4N DNA following treatment increased cell death, although both effects were modest. These results suggest that the function of these genes in the response to MLN4924 may not be fully realized by their effects on the cell cycle.
Upregulation of p53 and p21 is independent of Cdt1 or ATR.
In order to understand better the sequence of events for induction of checkpoints, we evaluated the effect of depleting CDT1, TP53, ATM, and ATR by Western blot on key proteins (Fig. 4) . These data demonstrated efficient knock-down of CDT1, TP53, and ATM. As expected, knock-down of CDT1 or ATR following treatment of cells with MLN4924 significantly reduced the phosphorylation of ATR substrates, including Rpa32 and Chk1, as well as the stabilization of claspin and the phosphorylation of Rb. Surprisingly, knock-down of CDT1 or ATR had little impact on increases in p53 or p21, whereas TP53 depletion was very efficient in blocking these effects. A spliceform of Puma was also unaffected by CDT1 depletion but reduced by TP53 depletion. Therefore, unexpectedly, the upregulation of p53 and p21 appears to be independent of DNA damage induced by Cdt1 stabilization, particularly as detected by ATR signaling. Fig. 3 ). Knock-down of ATR does efficiently block phosphorylation of Rpa32 (Fig. 4) .
Activation of ATR by MLN4924 in A375 Cells
Thus, activation of ATR or a critical downstream pathway may be blocked. Figure 5A compares MLN4924 with two control treatments known to activate ATR, aphidicolin and UV (34) .
Phosphorylation of the ATR targets Chk1, Mcm2, Nbs1, Rad17, and Rpa32 was similar between all three treatments, whereas Cdc25A, a substrate of Chk1 that is targeted for degradation by CRL1-βTRCP (35) MLN4924 treatment occurs in a single wave at ~10 h to half-maximal phosphorylation, consistent with these being substrates of a single kinase (Fig. 5B) . Therefore, MLN4924 clearly activates ATR, as previously described (12) . If MLN4924 directly interferes with the establishment of the ATR-dependent checkpoint, it appears to be through the stabilization of Cdc25A or events further downstream from ATR phosphorylation.
DISCUSSION
Our original interest in developing an NAE inhibitor was based on an emerging knowledge of the cullin-dependent degradation of many cancer relevant proteins, the dysregulation of which could provide a therapeutic benefit. Overall, the data obtained in our MLN4924 synthetic lethal screen align well with prior genetic studies on rereplication in that many of the genes affecting MLN4924 sensitivity are directly involved in the prereplication complex and DNA replication, including PCNA, MCM7, DTL, CDT1, TK1, RPA1, RRM2, and DHFR. Importantly, DNA damage repair (DDR) mechanisms were also well represented in these viability screen results.
These DDR mechanisms included p53, BRCA1/2, transcription coupled repair, base excision repair, and histones. Some aspects of these results could have been anticipated. For example, CRL4 has clear roles in transcription-coupled repair (36) and histone monoubiquitination (9). However, whereas multiple CRLs have been proposed to regulate p53 (37), the precise CRL for p53 relevant in this setting is not clear. Generally, characterization of the role of p53 and p21 in MLN4924 and rereplication biology has included intra-S-phase and G2/M checkpoint control and the induction of senescence (11, 38, 39) . Our data suggests that the intra-S-phase checkpoint is the most important in this setting. Finally, the roles of CRLs in (Fig. 3) , suggesting that the role of this complex in DNA replication and S-phase progression may account for this discordance (41) . Strikingly, early steps in BRCA1 complex formation are synthetic lethal whereas genes in later steps are suppressors, suggesting that MLN4924 may affect BRCA1 function at the transition between these two sets of genes, similar to the interaction between bortezomib and genes within the Myc-polyamine pathway (31) .
Discordance with HCT-116. We were initially surprised by the lack of overlap in the results between HCT-116 and A375 (Supplementary Table S2C HCT-116, also fail to arrest in S-phase following ionizing radation treatment, in contrast to mismatch repair proficient cells (43, 44) .
The evaluation of gene knock-down using orthogonal techniques generally gives a much greater sense of the biological impact of those genes. Notably, depletion of 69 genes gave significant cell cycle interactions with MLN4924 ( Fig. 2C and 3) . The combined viability and cell cycle data inform our understanding of the phenotypic consequences of NAE inhibition as discussed below and summarized in Figure 6 .
Regulation of Replication Origin Firing -The canonical response to rereplication stress is G2/M phase accumulation (Fig. 6 , blue arrows) (15, 16) , consistent with the results obtained for knock-down of replication genes (Fig. 2C ). Following treatment with MLN4924, the cell cycle impact of depletion of these genes was more divergent (Fig. 6, red arrows) . CAN-12-1729 10/18/2012 relatively slow induction of p53 and p21 (Fig. 5B, ~19 h to half-maximal levels). Additionally, depletion of ATR pathway genes did not affect sensitivity of HCT-116.
Intra-S-phase Checkpoint Activation
These results highlight one key difference between our data and the genetic interference studies on the regulation of replication origin firing, namely that very few genes within the ATRdependent checkpoints were found to interact with MLN4924 in the A375 viability screen.
Other researchers have suggested that MLN4924 may interfere with the function of the ATRdependent checkpoints (12, 51) . Our data suggests that the p21-dependent intra-S-phase checkpoint (52) may play a more dominant role in the response of A375 cells to NAE inhibition by MLN4924. Importantly, the ability of MLN4924 to induce the p21-dependent intra-S-phase checkpoint appears to be independent of Cdt1 stabilization or signaling through ATR (Fig. 4) .
Additionally, MLN4924 stabilizes Cdc25A (Fig. 5A) , which may account for the direct interference of MLN4924 in the activation of the ATR-dependent intra-S-phase checkpoint (53).
The impact of MLN4924 beyond Cdt1 stabilization demonstrates that MLN4924 will not simply mimic CDT1 overexpression.
A genome-wide siRNA viability screen provides an unbiased way of surveying possible drug mechanisms. We have used such a screen to characterize the genetics of sensitivity of the melanoma cell line A375 to MLN4924. Although it remains to be determined precisely how NAE inhibition impacts these multiple pathways, these results together with those investigating changes in protein expression following MLN4924 treatment (33, Supplementary Table S1K) will facilitate a better mechanistic understanding of the cullin-dependent regulatory and repair processes that compromise the viability of cancer cells. 
